Viral Kinetics During Acute Chikungunya Virus Infection: Insights Into Potential Role of Monoclonal Antibodies in Viral Clearance and Prophylaxis Using Mathematical Modeling
- 13 May 2025
- journal article
- Published by Wiley in Journal of Medical Virology
- Vol. 97 (5) , e70391
Abstract
Chikungunya virus (CHIKV), an arthritogenic alphavirus, is a significant public health threat in endemic and newly affected regions. This study investigates viral kinetics, immune responses, and the potential of monoclonal antibody (mAb) therapies to mitigate viraemia and transmission during acute CHIKV infection, providing novel insights into early intervention strategies. Using data from 29 patients in Cambodia, serial sampling and viral load quantification revealed that the population‐average peak viral load occurred ~1.87 days prior to symptom onset. Children demonstrated higher peak viral loads and faster replication rates compared to adults, although symptom severity and burden were similar across age groups. IgM antibodies appeared earlier in adults (median: 4.1 days) than in children (median: 5.1 days; p = 0.036). C‐reactive protein (CRP) levels were transiently elevated in about 50% of patients but showed no correlation with disease severity. Mathematical modeling highlighted that prophylactic mAb therapies, when administered 3 days before symptoms onset, could substantially reduce viral load and potentially prevent detectable viraemia. While these findings underscore the potential of mAbs as an early therapeutic strategy, further studies are necessary to evaluate the robustness of these results and assess their practical implications to curb CHIKV outbreaks by minimizing viraemia and presymptomatic transmission.Keywords
This publication has 48 references indexed in Scilit:
- Viremia and clinical manifestations in acute febrile patients of Chikungunya infection during the 2016 CHIKV outbreak in Delhi, IndiaInfectious Medicine, 2024
- Antibody-based therapeutic interventions: possible strategy to counter chikungunya viral infectionApplied Microbiology and Biotechnology, 2020
- Inflammatory biomarkers, disease activity index, and self-reported disability may be predictors of chronic arthritis after chikungunya infection: brief reportClinical Rheumatology, 2016
- Study of viremic profile in febrile specimens of chikungunya in Bandung, IndonesiaJournal of Clinical Virology, 2016
- Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and EgressCell, 2015
- Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya VirusCell Host & Microbe, 2015
- Correlation of plasma viral loads and presence of Chikungunya IgM antibodies with cytokine/chemokine levels during acute Chikungunya virus infectionJournal of Medical Virology, 2014
- Copy number variation of chikungunya ECSA virus with disease symptoms among Indian patientsJournal of Medical Virology, 2013
- Chikungunya fever: Epidemiology, clinical syndrome, pathogenesis and therapyAntiviral Research, 2013
- Development of a TaqMan® RT-PCR assay without RNA extraction step for the detection and quantification of African Chikungunya virusesJournal of Virological Methods, 2005